新冠疫情期间的播散性带状疱疹
Disseminated Herpes Zoster During COVID-19.
作者信息
Voisin Olivier, Deluca Nina, Mahé Annabelle, Lelorc'h Erwan, Hubert Sidonie, Ménage Elodie, Borie Marie-Françoise, Azria Philippe, Fite Charlotte, Pilmis Benoit, Mourad Jean-Jacques
机构信息
Department of Internal Medicine.
Department of Dermatology.
出版信息
Infect Dis Clin Pract (Baltim Md). 2021 Mar;29(2):e109-e110. doi: 10.1097/IPC.0000000000000971. Epub 2020 Nov 9.
Abstract
During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symptoms secondary to COVID-19 have been frequently described. This is the first case that demonstrates the recurrence of herpes zoster during a SARS-CoV-2 infection.
摘要
在新型冠状病毒肺炎大流行期间，医生报告了多种皮肤病情况。鉴于此背景，这些皮损被标记为继发于新型冠状病毒感染。我们报告了1例新型冠状病毒感染住院患者带状疱疹复发的病例。皮疹出现在住院第15天，此时患者正从重症中恢复。局部拭子显示水疱内存在水痘-带状疱疹病毒。新型冠状病毒肺炎继发的皮肤症状已有频繁描述。这是首例证明新型冠状病毒感染期间带状疱疹复发的病例。
相似文献
1
Disseminated Herpes Zoster During COVID-19.
Infect Dis Clin Pract (Baltim Md). 2021 Mar;29(2):e109-e110. doi: 10.1097/IPC.0000000000000971. Epub 2020 Nov 9.
2
A Rare Case of Varicella-Zoster Virus Reactivation Following Recovery From COVID-19.
Cureus. 2021 Jan 1;13(1):e12423. doi: 10.7759/cureus.12423.
3
A Rare Case of Herpes Zoster in an Adult Patient Recovered From Symptomatic Reinfection of COVID-19.
Cureus. 2021 Jul 8;13(7):e16274. doi: 10.7759/cureus.16274. eCollection 2021 Jul.
4
An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report.
BMC Infect Dis. 2020 Jun 29;20(1):454. doi: 10.1186/s12879-020-05192-3.
5
Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic - A case report.
Indian J Ophthalmol. 2021 Sep;69(9):2532-2535. doi: 10.4103/ijo.IJO_1644_21.
6
Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19.
Cureus. 2020 Jul 4;12(7):e8998. doi: 10.7759/cureus.8998.
7
Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00002-18. Print 2018 Jun 1.
8
Case of atypical disseminated herpes zoster in a patient with COVID-19: A diagnostic challenge in COVID era.
Clin Case Rep. 2022 Feb 2;10(2):e05342. doi: 10.1002/ccr3.5342. eCollection 2022 Feb.
9
Disseminated Varicella-zoster Virus Infection Causing Fatal Pneumonia in an Immunocompromised Patient with Chronic Interstitial Pneumonia.
Intern Med. 2021 Apr 1;60(7):1077-1082. doi: 10.2169/internalmedicine.5396-20. Epub 2020 Nov 9.
10
A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine.
Cureus. 2023 Jan 19;15(1):e33962. doi: 10.7759/cureus.33962. eCollection 2023 Jan.
引用本文的文献
1
Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.
BMC Infect Dis. 2023 Dec 6;23(1):854. doi: 10.1186/s12879-023-08809-5.
2
Disseminated Herpes Zoster Following Protein Subunit and mRNA COVID-19 Vaccination in Immunocompetent Patients: Report of Two Cases and Literature Review.
Medicina (Kaunas). 2023 Aug 25;59(9):1542. doi: 10.3390/medicina59091542.
3
Clinico-Demographic Profiles of Herpes Zoster Cases in Patients With and Without COVID-19 Infection During the Pandemic: A Retrospective Analysis of 32 Cases.
Cureus. 2023 Jun 6;15(6):e40063. doi: 10.7759/cureus.40063. eCollection 2023 Jun.
4
A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine.
Cureus. 2023 Jan 19;15(1):e33962. doi: 10.7759/cureus.33962. eCollection 2023 Jan.
5
A rare case of AIDS co-infected with COVID-19 presenting with disseminated Herpes zoster complicated with CMV and Varicella zoster virus meningoencephalitis.
Acta Biomed. 2022 Dec 16;93(6):e2022326. doi: 10.23750/abm.v93i6.13464.
6
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.
Eur J Intern Med. 2022 Oct;104:73-79. doi: 10.1016/j.ejim.2022.07.022. Epub 2022 Aug 1.
7
Characteristics of herpes zoster infection in patients with COVID-19: a systematic scoping review.
Int J Dermatol. 2022 Sep;61(9):1087-1092. doi: 10.1111/ijd.16221. Epub 2022 May 3.
8
Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States.
Open Forum Infect Dis. 2022 Mar 9;9(5):ofac118. doi: 10.1093/ofid/ofac118. eCollection 2022 May.
9
A Case Report of Varicella Zoster Meningitis as Co-Infection With Breakthrough COVID-19 in an Immunocompetent Patient.
J Korean Med Sci. 2022 Feb 28;37(8):e61. doi: 10.3346/jkms.2022.37.e61.
10
Case of atypical disseminated herpes zoster in a patient with COVID-19: A diagnostic challenge in COVID era.
Clin Case Rep. 2022 Feb 2;10(2):e05342. doi: 10.1002/ccr3.5342. eCollection 2022 Feb.
本文引用的文献
1
T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
J Infect Dis. 2020 Jun 29;222(2):198-202. doi: 10.1093/infdis/jiaa252.
2
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
3
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients.
J Am Acad Dermatol. 2020 Jul;83(1):280-285. doi: 10.1016/j.jaad.2020.04.044. Epub 2020 Apr 16.
4
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
5
Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.
Clin Infect Dis. 2020 Oct 23;71(7):e125-e134. doi: 10.1093/cid/ciz1090.
6
Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review.
Rheumatol Adv Pract. 2019 Feb 12;3(1):rkz004. doi: 10.1093/rap/rkz004. eCollection 2019.
7
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
Joint Bone Spine. 2016 Jul;83(4):412-5. doi: 10.1016/j.jbspin.2015.07.009. Epub 2015 Dec 22.
8
Viremia in acute herpes zoster.
J Infect Dis. 2009 Jul 1;200(1):26-32. doi: 10.1086/599381.
9
Exposition to chickenpox of two children with autoinflammatory syndromes under treatment with anakinra.
Rheumatol Int. 2008 Jun;28(8):793-6. doi: 10.1007/s00296-007-0515-2. Epub 2008 Jan 3.
10
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Ann Rheum Dis. 2008 Mar;67(3):302-8. doi: 10.1136/ard.2007.076034. Epub 2007 Oct 18.
Zotero 插件